Bal Pharma Clarifies No Price Sensitive Information

Bal Pharma Ltd has responded to stock exchange queries regarding significant price movements in its scrip. The company stated that it does not possess any price-sensitive or material information that could explain the volatility. Bal Pharma confirmed that all necessary disclosures under SEBI regulations have been made within the stipulated timelines. The company attributes the price fluctuations to natural market-driven factors and denies any management involvement in influencing the share price. They reiterate their commitment to compliance and timely disclosures.